SARA LARA: Open Payments
NPI 1326408386 · LITTLE RIVER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,331 in 96 payments from 21 companies in 2025. Trend: 2023 $1,806 · 2024 $4,660 · 2025 $2,331
Food & beverage: $2,331
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 11 | $330 |
| AstraZeneca Pharmaceuticals LP | 13 | $273 |
| GlaxoSmithKline, LLC. | 15 | $244 |
| Insmed, Inc. | 7 | $221 |
| GENZYME CORPORATION | 6 | $173 |
| Regeneron Healthcare Solutions, Inc. | 6 | $135 |
| SANOFI-AVENTIS U.S. LLC | 1 | $124 |
| Verona Pharma, Inc. | 5 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $115 |
| Grifols USA, LLC | 4 | $107 |
Products named: Tyvaso, DUPIXENT, Arikayce, TRELEGY ELLIPTA, TZIELD, Ohtuvayre, HYQVIA, BREZTRI.
Industry payments across SC — which companies pay providers there.
